Evidence map›Paper›PMID 32173743›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis.

Aaloke Mody, David V Glidden, Ingrid Eshun-Wilson, Kombatende Sikombe, Sandra Simbeza, Njekwa Mukamba, Paul Somwe, Laura K Beres, Jake Pry, Carolyn Bolton-Moore and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06803316 (Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06803316 completednot on this mapstarted 2022, after this paper: background citation

Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia

Typeobservational_patient_registrySponsorCentre for Infectious Disease Research in ZambiaRan2022 to 2025Enrolled658ConditionsHIV Antiretroviral Therapy (ART) Adherence
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aaloke ModyDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
David V GliddenDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Ingrid Eshun-WilsonDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Kombatende SikombeCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Sandra SimbezaCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Njekwa MukambaCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Paul SomweCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Laura K BeresDepartment of International Health, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
Jake PryDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Carolyn Bolton-MooreCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Nancy PadianDivision of Epidemiology, University of California, Berkeley, Berkeley, California, USA.
Charles B HolmesDepartment of Medicine, Georgetown University, Washington, D.C., USA.
Izukanji SikazweCentre for Infectious Diseases Research in Zambia, Lusaka, Zambia.
Elvin H GengDivision of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
NIAID NIH HHS K24 AI134413NIAID NIH HHS P30 AI027763NIAID NIH HHS T32 AI060530
6 · The paper itself

Abstract

backgroundRetention in human immunodeficiency virus (HIV) care is dynamic, with patients frequently transitioning in and out of care. Analytical approaches (eg, survival analyses) commonly used to assess HIV care cascade outcomes fail to capture such transitions and therefore incompletely represent care outcomes over time.

methodsWe analyzed antiretroviral therapy (ART)-eligible adults newly linking to care at 64 clinics in Zambia between 1 April 2014 and 31 July 2015. We used electronic medical record data and supplemented these with updated care outcomes ascertained by tracing a multistage random sample of patients lost to follow-up (LTFU, >90 days late for last appointment). We performed multistate analyses, incorporating weights from sampling, to estimate the prevalence of 9 care states over time since linkage with respect to ART initiation, retention in care, transfers, and mortality.

resultsIn sum, 23 227 patients (58% female; median age 34 years [interquartile range 28-41]) were ART-eligible at enrollment. At 1 year, 75.2% had initiated ART and were in care: 61.8% were continuously retained, 6.1% had reengaged after LTFU, and 7.3% had transferred. Also, 10.1% were LTFU within 7 days of enrollment, and 15.2% were LTFU at 1 year (6.7% prior to ART). One year after LTFU, 51.6% of those LTFU prior to ART remained out of care compared to 30.2% of those LTFU after initiating ART. Overall, 6.9% of patients had died by 1 year with 3.0% dying prior to ART.

conclusionMultistate analyses provide more complete assessments of longitudinal HIV cascade outcomes and reveal treatment gaps at distinct timepoints in care that will still need to be addressed even with universal treatment.

Indexed as

Anti-HIV AgentsHIV InfectionsAdultElectronic Health RecordsFemaleHumansLost to Follow-UpMaleSurvival AnalysisZambiaAnti-HIV AgentsHIV care cascademortalitymultistate analysisretention in careZambia

Identifiers

PMID32173743
PMCPMC7744998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.